Modupe Kuti
University of Ibadan
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Modupe Kuti.
Journal of Clinical Pathology | 2011
Modupe Kuti; Fayeofori Mpakabaori Abbiyesuku; Kehinde Simeon Akinlade; Om Akinosun; Kayode Adedapo; Jokotade Oluremilekun Adeleye; Olubukola Adeponle Adesina
Aims This study aimed to determine the prevalence and relationships with known risk factors of gestational diabetes mellitus (GDM) at University College Hospital, Ibadan, Nigeria. Methods Records of all women referred for oral glucose tolerance testing at the metabolic research unit of the Hospital over a 2 year period were reviewed. Diagnosis of GDM was made in accordance with WHO criteria. GDM diagnosis was classified as early and late based on a gestational age <24 weeks and >24 weeks respectively. Body mass index (BMI) measurements were performed for women who presented in the first trimester. Various statistical tools including student t test and Pearsons coefficient of correlation were used. Results A total of 765 records were reviewed. The crude prevalence rate was 13.9%. The prevalence rate among women in the first trimester was highest at 17.4% although most of the diagnoses were made in the third trimester (55.7%). A positive family history and a family history of GDM were associated significantly with a higher fasting and 2 h post-load glucose values, irrespective of current GDM diagnosis. The most consistent associations with a diagnosis of GDM were a positive family history and a history of GDM. Age above 30 years at oral glucose testing also showed significant association. There was no BMI threshold associated with a significant risk of GDM for those women presenting in the first trimester. Conclusions GDM is a common metabolic condition in Nigeria. Onset before the 24th week of pregnancy is not uncommon.
American Journal of Clinical Pathology | 2016
Kenneth A. Fleming; Mahendra Naidoo; Michael L. Wilson; John Flanigan; Susan Horton; Modupe Kuti; Looi Lm; Christopher P. Price; Kun Ru; Abdul Ghafur; Jianxiang Wang; Néstor Lago
Objectives: We review the current status of pathology services in low- and middle-income countries and propose an “essential pathology package” along with estimated costs. The purpose is to provide guidance to policy makers as countries move toward universal health care systems. Methods: Five key themes were reviewed using existing literature (role of leadership; education, training, and continuing professional development; technology; accreditation, management, and quality standards; and reimbursement systems). A tiered system is described, building on existing proposals. The economic analysis draws on the very limited published studies, combined with expert opinion. Results: Countries have underinvested in pathology services, with detrimental effects on health care. The equipment needs for a tier 1 laboratory in a primary health facility are modest (
The Lancet | 2018
Susan Horton; Richard Sullivan; John Flanigan; Kenneth A. Fleming; Modupe Kuti; Looi Lm; Sanjay A Pai; Mark Lawler
2-
Journal of the International Association of Providers of AIDS Care | 2015
Modupe Kuti; Olubukola A. Adesina; Oluwatosin Alaba Awolude; Babatunde O. Ogunbosi; Samuel A. Fayemiwo; Joshua O. Akinyemi; Adedotun A. Adetunji; Achiaka E. Irabor; Georgina N. Odaibo; Okonkwo Prosper; Babafemi Taiwo; David O. Olaleye; Robert L. Murphy; Phyllis J. Kanki; Isaac F. Adewole
5,000), compared with
Clinical Ophthalmology | 2008
Adeyinka Ashaye; Ayodeji Arije; Modupe Kuti; Bolutife Ayokunnu Olusanya; Ezekiel Ayeni; Adesoji Fasanmade; Kehinde Sola Akinlade; Millicent Obajimi; Jokotade Oluremilekun Adeleye
150,000 to
African Health Sciences | 2017
Joshua O. Akinyemi; Babatunde O. Ogunbosi; Adetona S. Fayemiwo; Olubukola A. Adesina; Michael Obaro; Modupe Kuti; Olutosin A. Awolude; David O. Olaleye; Isaac F. Adewole
200,000 in a district hospital, and higher in a referral hospital (depending on tests undertaken). Access to a national (or regional) specialized laboratory undertaking disease surveillance and registry is important. Recurrent costs of appropriate laboratories in district and referral hospitals are around 6% of the hospital budget in midsized hospitals and likely decline in the largest hospitals. Primary health facilities rely largely on single-use tests. Conclusions: Pathology is an essential component of good universal health care.
Nigerian Journal of Clinical Practice | 2017
Jo Adeleye; Modupe Kuti
Modern, affordable pathology and laboratory medicine (PALM) systems are essential to achieve the 2030 Sustainable Development Goals for health in low-income and middle-income countries (LMICs). In this last in a Series of three papers about PALM in LMICs, we discuss the policy environment and emphasise three crucial high-level actions that are needed to deliver universal health coverage. First, nations need national strategic laboratory plans; second, these plans require adequate financing for implementation; and last, pathologists themselves need to take on leadership roles to advocate for the centrality of PALM to achieve the Sustainable Development Goals for health. The national strategic laboratory plan should deliver a tiered, networked laboratory system as a central element. Appropriate financing should be provided, at a level of at least 4% of health expenditure. Financing of new technologies such as molecular diagnostics is challenging for LMICs, even though many of these tests are cost-effective. Point-of-care testing can substantially reduce test-reporting time, but this benefit must be balanced with higher costs. Our research analysis highlights a considerable deficiency in advocacy for PALM; pathologists have been invisible in national and international health discourse and leadership. Embedding PALM in LMICs can only be achieved if pathologists advocate for these services, and undertake leadership roles, both nationally and internationally. We articulate eight key recommendations to address the current barriers identified in this Series and issue a call to action for all stakeholders to come together in a global alliance to ensure the effective provision of PALM services in resource-limited settings.
Wellcome Open Research | 2016
Haleema Shakur; Bukola Fawole; Modupe Kuti; Oladapo Olayemi; Adenike Bello; Olayinka Ogunbode; Taiwo R. Kotila; Chris Aimakhu; Sumaya Huque; Meghann Gregg; Ian Roberts
Aims: This study aimed to describe the prevalence and pattern of lipid abnormalities among antiretroviral therapy (ART)-naive HIV patients, understand if there is any relationship to virologic and immunologic status, and discuss the implications for care. Methods: This was a cross-sectional study in which baseline demographic, clinical, and laboratory data of all ART-naive HIV-infected individuals recruited into the adult ARV clinic, University College Hospital, Ibadan, between January and December 2006, were analyzed. Results: In total, 1316 ART-naive HIV-infected persons were recruited in the period. Females subjects and participants aged ≦35 years accounted for 67.1% and 57.7% of all participants, respectively. At least 1 abnormal lipid fraction was seen in 73.3% of participants. It was observed that in 11.5% participants the total cholesterol (TC) was ≧5.2 mmol/L, in 2.7% the low-density lipoprotein cholesterol (LDL)-C was >4.1 mmol/L in 56.5% the high-density lipoprotein cholesterol (HDL)-C was <1.0 mmol/L, and in 27.6% the triglyceride (TG) was >1.7 mmol/L. The TC, LDL-C, and HDL-C were all significantly positively correlated with CD4 counts and negatively correlated with viral load. On the contrary, the TG levels were negatively correlated with CD4 counts and positively correlated with viral load. Multivariate linear analysis showed a significant relationship between all the lipid parameters and viral load. CD4 counts were only significantly associated with TC. Conclusions: A significant burden of dyslipidemia exists among ART-naive HIV-infected persons. Low HDL-C was the most frequently observed abnormality. The abnormalities related more with viral load levels than with CD4 counts. Dyslipidemia screening should be done in ART-naive HIV-infected persons. Simple healthy lifestyle changes should be emphasized, with other care given to those with the disorder.
Wellcome Open Research | 2018
Haleema Shakur-Still; Ian Roberts; Bukola Fawole; Modupe Kuti; Oladapo Olayemi; Adenike Bello; Sumaya Huque; Olayinka Ogunbode; Taiwo R. Kotila; Chris Aimakhu; Olujide Okunade; Tolulase Olutogun; Cecilia Olusade Adetayo; Kastriot Dallaku; Ulrich Mansmann; Beverley J. Hunt; Tracey Pepple; Eni Balogun
Objective To determine the prevalence of diabetic retinopathy among patients attending the diabetic clinics of a tertiary hospital in Nigeria. Methodology We examined the eyes of 76 patients with type 2 diabetes mellitus between July 2003 and January 2004 using dilated fundoscopy at the eye clinic of the University College Hospital, Ibadan. The results were compared with published figures. Results Mean age of patients was 57.5 ± 10.4 years. Thirty–two patients (42.1%) had diabetic retinopathy. Of these, one patient had features of proliferative diabetic retinopathy while the other patients had non-proliferative diabetic retinopathy. Majority (53.1%) of those who had retinopathy had diabetes for more than 10 years, while 21.4% of patients without retinopathy had diabetes for more than 10 years (p = 0.005). The mean serial post-prandial plasma glucose of those who had retinopathy was higher when compared with the mean for those who did not have retinopathy (248.7 mg/dl vs 178.3 mg/dl; p = 0.003). Conclusion The prevalence of diabetic retinopathy in our patients is higher than was previously reported in earlier studies. Patients with diabetes ought to be referred for ophthalmological evaluation and follow-up which they should be actively encouraged to attend.
Nigerian Journal of Clinical Practice | 2018
Sani Adamu; Om Akinosun; Fayeofori Mpakabaori Abbiyesuku; Modupe Kuti; Jibril M El-Bashir; Jd Abubakar
BACKGROUND In view of the maturing HIV epidemic in sub-Saharan Africa, better understanding of its epidemiology among older adults is necessary in order to design appropriate care and treatment programmes for them. OBJECTIVES To describe the demographic and epidemiological characteristics of HIV opportunistic infections among newly enrolled patients aged 50 years and above in Ibadan, South-West Nigeria. METHODS Analysis of data extracted from electronic records of 17, 312 subjects enrolled for HIV/AIDS care and treatment between January 2006 and December 2014 at the ART clinic, University College Hospital, Ibadan. RESULTS Age of the patients ranged from 18 to 90 years with a mean of 36.4 years (SD= 10.3) with older adults constituting 12.0% (2075). Among older adults, about half (52.9%) were females. Majority (59.1%) were currently married while 25.9% were widowed. Prevalence of opportunistic infections was 46.6%. The commonest opportunistic infections (OIs) were: oral candidiasis (27.6%), chronic diarrhoea (23.5% and peripheral neuropathy (14.8%). Significant factors associated with opportunistic infections in older adults were: CD4 count less than 350 (OR=3.12, CI: 2.29-4.25) and hepatitis C virus co-infection (OR=2.17, CI: 1.14-4.13). CONCLUSION There is need for prompt response to the peculiar challenges associated with the emerging shift in the epidemiology of HIV and associated infections in sub-Saharan Africa.